BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wyse JM, Chen YI, Sahai AV. Celiac plexus neurolysis in the management of unresectable pancreatic cancer: When and how? World J Gastroenterol 2014; 20(9): 2186-2192 [PMID: 24605017 DOI: 10.3748/wjg.v20.i9.2186] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Neuwersch-Sommeregger S, Köstenberger M, Stettner H, Pipam W, Breschan C, Feigl G, Likar R, Egger M. CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients. Pain Ther 2021;10:1593-603. [PMID: 34546553 DOI: 10.1007/s40122-021-00317-1] [Reference Citation Analysis]
2 Kongsgaard UE. Letter to the Editor regarding "CT guided neurolytic blockade of the coeliac plexus in patients with advanced and intractably painful pancreatic cancer". Scand J Pain 2018;18:759. [PMID: 30048239 DOI: 10.1515/sjpain-2018-0110] [Reference Citation Analysis]
3 Mohamed RE, Amin MA, Omar HM. Computed tomography-guided celiac plexus neurolysis for intractable pain of unresectable pancreatic cancer. The Egyptian Journal of Radiology and Nuclear Medicine 2017;48:627-37. [DOI: 10.1016/j.ejrnm.2017.03.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
4 Filippiadis DK, Tselikas L, Tsitskari M, Kelekis A, de Baere T, Ryan AG. Percutaneous Neurolysis for Pain Management in Oncological Patients. Cardiovasc Intervent Radiol 2019;42:791-9. [DOI: 10.1007/s00270-019-02185-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
5 Dumitrescu A, Aggarwal A, Chye R. A retrospective case series of patients who have undergone coeliac plexus blocks for the purpose of alleviating pain due to intra-abdominal malignancy. Cancer Rep (Hoboken) 2020;3:e1265. [PMID: 32687682 DOI: 10.1002/cnr2.1265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Uysal A, Unal E, Karaosmanoglu AD, Arellano R, Ciftci TT, Akinci D, Akhan O. The role of interventional radiology in the treatment of patients with pancreatic cancer. Br J Radiol 2021;94:20200702. [PMID: 33156695 DOI: 10.1259/bjr.20200702] [Reference Citation Analysis]
7 Benson M, Pfau P. Pain relief and the celiac plexus: Can burning exceed injecting? Gastrointest Endosc 2019;89:67-8. [PMID: 30567685 DOI: 10.1016/j.gie.2018.09.033] [Reference Citation Analysis]
8 Martin-Richard M, Ginès A, Ayuso JR, Sabater L, Fabregat J, Mendez R, Fernández-Esparrach G, Molero X, Vaquero EC, Cuatrecasas M, Ferrández A, Maurel J; Comité multidisciplinar para la actualización de las recomendaciones para el manejo de las lesiones pre-malignas y el adenocarcinoma de páncreas. [Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma]. Med Clin (Barc) 2016;147:465.e1-8. [PMID: 27726847 DOI: 10.1016/j.medcli.2016.07.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Macarulla T, Carrato A, Díaz R, García A, Laquente B, Sastre J, Álvarez R, Muñoz A, Hidalgo M. Management and supportive treatment of frail patients with metastatic pancreatic cancer. J Geriatr Oncol 2019;10:398-404. [PMID: 30005980 DOI: 10.1016/j.jgo.2018.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Zylberberg HM, Nagula S, Rustgi SD, Aronson A, Kessel E, Kumta NA, Dimaio CJ, Lucas AL. Celiac Plexus Neurolysis Is Associated With Decreased Survival in Patients With Pancreatic Cancer: A Propensity Score Analysis. Pancreas 2022;51:153-8. [DOI: 10.1097/mpa.0000000000001992] [Reference Citation Analysis]
11 Edelstein MR, Gabriel RT, Elbich JD, Wolfe LG, Sydnor MK. Pain Outcomes in Patients Undergoing CT-Guided Celiac Plexus Neurolysis for Intractable Abdominal Visceral Pain. Am J Hosp Palliat Care 2017;34:111-4. [PMID: 26345319 DOI: 10.1177/1049909115604670] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Urits I, Jones MR, Orhurhu V, Peck J, Corrigan D, Hubble A, Andrews M, Feng R, Manchikanti L, Kaye AD, Kaye RJ, Viswanath O. A Comprehensive Review of the Celiac Plexus Block for the Management of Chronic Abdominal Pain. Curr Pain Headache Rep 2020;24:42. [PMID: 32529305 DOI: 10.1007/s11916-020-00878-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Verma A, Shukla S, Verma N. Diagnosis, Preoperative Evaluation, and Assessment of Resectability of Pancreatic and Periampullary Cancer. Indian J Surg 2015;77:362-70. [PMID: 26722198 DOI: 10.1007/s12262-015-1370-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Tepelenis K, Tsimogiannis KE, Zikos N, Koulas S, Pappas-Gogos G, Benetatos N, Tsimogiannis I, Tsimoyiannis EC. Laparoscopic versus open approach to neurolytic celiac plexus block in inoperable pancreatic cancer. ANZ J Surg 2018;88:E767-71. [PMID: 29763984 DOI: 10.1111/ans.14560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
15 Woo SM, Song MK, Lee M, Joo J, Kim DH, Kim JH, Han SS, Park SJ, Kim TH, Lee WJ. Effect of Early Management on Pain and Depression in Patients with Pancreatobiliary Cancer: A Randomized Clinical Trial. Cancers (Basel) 2019;11:E79. [PMID: 30641928 DOI: 10.3390/cancers11010079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
16 Vas L, Phanse S, Pai R. A New Perspective of Neuromyopathy to Explain Intractable Pancreatic Cancer Pains; Dry Needling as an Effective Adjunct to Neurolytic Blocks. Indian J Palliat Care 2016;22:85-93. [PMID: 26962286 DOI: 10.4103/0973-1075.173957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Hickman K, Godfrey E, Ajithkumar T. Endoscopic ultrasound-guided neurolysis in advanced pancreatic cancer: current status. BMJ Support Palliat Care 2021:bmjspcare-2021-002905. [PMID: 34635545 DOI: 10.1136/bmjspcare-2021-002905] [Reference Citation Analysis]
18 Klose J, Rieder S, Ronellenfitsch U. Surgical and interventional treatment options in unresectable gastrointestinal cancer. Surgery in Practice and Science 2021;5:100037. [DOI: 10.1016/j.sipas.2021.100037] [Reference Citation Analysis]
19 Abdelbaser I, Shams T, El-Giedy AA, Elsedieq M, Ghanem MA. Direct intraoperative versus percutaneous computed tomographyguided celiac plexus neurolysis in non-resectable pancreatic cancer: A randomized, controlled, non-inferiority study. Rev Esp Anestesiol Reanim (Engl Ed) 2021:S0034-9356(21)00141-9. [PMID: 34565567 DOI: 10.1016/j.redar.2020.12.016] [Reference Citation Analysis]
20 Dong D, Zhao M, Zhang J, Huang M, Wang Y, Qi L, Wan CF, Yu X, Song T. Neurolytic Splanchnic Nerve Block and Pain Relief, Survival, and Quality of Life in Unresectable Pancreatic Cancer: A Randomized Controlled Trial. Anesthesiology 2021;135:686-98. [PMID: 34398950 DOI: 10.1097/ALN.0000000000003936] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Saletta GA, Sprott H. Bedside Neurolysis for Palliative Care of Critically Ill Patients With Pancreatic Cancer. J Ultrasound Med 2019;38:1907-11. [PMID: 30480337 DOI: 10.1002/jum.14881] [Reference Citation Analysis]
22 Molnár I, Hegyi G, Zsom L, Saahs C, Vagedes J, Kapócs G, Kovács Z, Sterner MG, Szőke H. Celiac plexus block increases quality of life in patients with pancreatic cancer. J Pain Res 2019;12:307-15. [PMID: 30679920 DOI: 10.2147/JPR.S186659] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Grubert RM, Tibana TK, Missirian LA, Neves TMHD, Nunes TF. Computed tomography-guided percutaneous neurolysis of celiac plexus: technical description. Radiol Bras 2020;53:114-5. [PMID: 32336827 DOI: 10.1590/0100-3984.2019.0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Lee KG, Roy V, Laszlo M, Atkins KM, Lin KJ, Tomassian S, Hendifar AE. Symptom Management in Pancreatic Cancer. Curr Treat Options Oncol 2021;22:8. [PMID: 33387071 DOI: 10.1007/s11864-020-00801-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Higuera O, Ghanem I, Nasimi R, Prieto I, Koren L, Feliu J. Management of pancreatic cancer in the elderly. World J Gastroenterol 2016; 22(2): 764-775 [PMID: 26811623 DOI: 10.3748/wjg.v22.i2.764] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 52] [Article Influence: 11.5] [Reference Citation Analysis]
26 Haumann J, Joosten E(A, Everdingen MHVDB. Pain prevalence in cancer patients: status quo or opportunities for improvement? Current Opinion in Supportive & Palliative Care 2017;11:99-104. [DOI: 10.1097/spc.0000000000000261] [Cited by in Crossref: 33] [Cited by in F6Publishing: 5] [Article Influence: 6.6] [Reference Citation Analysis]
27 Jara C, Del Barco S, Grávalos C, Hoyos S, Hernández B, Muñoz M, Quintanar T, Meana JA, Rodriguez C, de Las Peñas R. SEOM clinical guideline for treatment of cancer pain (2017). Clin Transl Oncol 2018;20:97-107. [PMID: 29127593 DOI: 10.1007/s12094-017-1791-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]